August 13, 2025

Alex Gorsky, former CEO of Johnson & Johnson, on how AI could reduce drug errors and save lives

Explore more founder stories
Related Videos
No items found.
Go Deeper Into the Data

Explore ICONIQ’s proprietary research, benchmarking, and analytics shaping how leading companies scale and perform.

Explore Research
Stay Close to the Signal

Get ICONIQ’s latest research, insights, and founder conversations delivered to your inbox.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By subscribing, you agree to receive marketing communications from ICONIQ or its affiliates. Formore information, please see our Privacy Policy.

Contact

Legal

Unless otherwise specified, the communications on this website are issued by ICONIQ Capital, LLC (“ICONIQ").  This website is for general information purposes only and is subject to change without notice.  Nothing on this website should be construed as an offer, invitation or general solicitation to buy or sell any investment or securities, provide investment advisory services, make personal recommendations or to engage in any other transaction, and must not be relied upon in connection with any investment decision.  Information on this website is not intended to and does not constitute financial, accounting, tax, legal, investment, consulting or other professional advice or services.

ICONIQ Partners (UK) LLP (FRN:973080) is an Appointed Representative of Kroll Securities Limited (FRN:466588) who are authorised and regulated by the Financial Conduct Authority. ICONIQ Capital (Singapore)Pte. Ltd. is licensed and regulated by the Monetary Authority of Singapore under the Securities and Futures Act (Cap. 289) and operates independently from ICONIQ Capital, LLC. The services and products described herein may vary by jurisdiction and are subject to the laws and regulations applicable in the relevant jurisdiction.

None of the information on this website constitutes a financial promotion within the meaning of section 21 of the UK Financial Service and Markets Act 2000 (as amended).

Any communications on this website are directed at, and intended for, only persons who are experienced institutional or professional investors (“professional investors”) as defined by applicable law and regulation. Any person that is not a professional investor is not an intended recipient of the communications on this website.

ICONIQ's policies for how it uses information that you provide, or that it collects through your use of its website are incorporated by reference for all purposes, and can be found here.  Please note that by visiting ICONIQ's website, you agree to and acknowledge its privacy policies.

Assets under management are calculated using net asset value plus uncalled capital commitments of all ICONIQ accounts and funds as of a recent date. Such figures are approximate, unaudited and subject to change.

© ICONIQ Capital, LLC